BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 2, 2016
View Archived Issues
Benitec to terminate HCV program
Read More
Novel sulfiredoxin inhibitor induces selective death of cancer cells
Read More
Lumosa Therapeutics describes novel thrombolytic agent DC-009
Read More
EMA committee recommends approval of Idelvion for hemophilia B
Read More
Innovate licenses larazotide acetate from Alba Therapeutics
Read More
Novel anti-HIV combinectin BMS-986197 may have enhanced resistance profile
Read More
Cebranopadol demonstrates significant improvements in lower backpain in phase IIb study
Read More
Siemens to release genetic assay for early detection of Zika virus
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group patents TLR7 agonists
Read More
Hydra Biosciences reports development of TRPC5 antagonists
Read More
FLAG-003 awarded E.U. orphan drug designation for glioma
Read More
MAA submitted for tivozanib as first-line treatment of advanced RCC
Read More
Z53 Therapeutics is launched as a novel oncology start-up
Read More
Modified version of troponin C modulates cardiac contractility in vivo
Read More
Preclinical and phase I results presented for HIV treatment/prophylaxis candidate MK-8591
Read More
Polymorphism in galectin-3 lectin domain is associated with beta-lactam allergy
Read More
Aytu BioScience and Hybridyne enter study agreement for trial using ProxiScan and ProstaScint
Read More
Pfizer initiates phase I study of PF-06801591
Read More
FDA approves Odefsey single-tablet regimen for HIV-1 infection
Read More
FDA announces new Orphan Products Natural History Grants program
Read More
Horizon Discovery and Centauri Therapeutics form Avvinity Therapeutics
Read More
Evgen cleared to begin phase II trial of SFX-01 for aneurysmal subarachnoid hemorrhage
Read More
ProStrakan signs agreement to acquire Moventig rights in Europe
Read More
FDA grants orphan drug designation to BMN-270 gene therapy for hemophilia A
Read More
New phase II trial investigates sulfatinib for thyroid cancer
Read More
First-in-human study of oral antimalarial drug SJ-733
Read More
Hikma closes acquisition of Roxane Laboratories and Boehringer Ingelheim Roxane
Read More